<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34918211</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-7558</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>International journal of behavioral medicine</Title><ISOAbbreviation>Int J Behav Med</ISOAbbreviation></Journal><ArticleTitle>Characterizing the COVID-19 Illness Experience to Inform the Study of Post-acute Sequelae and Recovery.</ArticleTitle><Pagination><StartPage>610</StartPage><EndPage>623</EndPage><MedlinePgn>610-623</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12529-021-10045-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There is an urgent need to fully understand the impact of variable COVID-19 experiences and the optimal management of post-acute sequelae of SARS-CoV-2 infection. We characterized the variability in the acute illness experience and ongoing recovery process from participants in a COVID-19 recovery cohort study in Northern California in 2020.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">We completed 24 semi-structured in-depth interviews with adults with confirmed positive SARV-CoV-2 nucleic acid amplification test result, had recovered or were recovering from acute infection, and underwent serial evaluations. We purposefully sampled English- and Spanish-speaking adults with asymptomatic, mild, and severe symptomatic infection, including those who were hospitalized and those with HIV co-infection. We used a thematic analysis to analyze interviews and identify salient themes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">After integrating the thematic analysis with clinical data, we identified key themes: (1) across symptom profiles and severity, experiencing COVID-19 was associated with psychological distress; (2) symptomatic infection carried uncertainty in symptom presentation and ongoing recovery (e.g., long COVID); and (3) health information-seeking behavior was facilitated by access to medical care and uncertainty with the recovery process.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our data informs the emerging field of "long COVID" research and shows a need to provide information and continuous support to persons with post-acute sequelae to ensure they feel secure along the path to recovery.</AbstractText><CopyrightInformation>&#xa9; 2021. International Society of Behavioral Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Santiago-Rodriguez</LastName><ForeName>Edda I</ForeName><Initials>EI</Initials><AffiliationInfo><Affiliation>Center for AIDS Prevention Studies, University of California, San Francisco, 550 16th Street, 3rd Floor, San Francisco, CA, 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maiorana</LastName><ForeName>Andres</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for AIDS Prevention Studies, University of California, San Francisco, 550 16th Street, 3rd Floor, San Francisco, CA, 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peluso</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Division of HIV, ID and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoh</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of HIV, ID and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tai</LastName><ForeName>Viva</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Division of HIV, ID and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fehrman</LastName><ForeName>Emily A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Division of HIV, ID and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernandez</LastName><ForeName>Yanel</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of HIV, ID and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres</LastName><ForeName>Leonel</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of HIV, ID and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spinelli</LastName><ForeName>Matthew A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Division of HIV, ID and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gandhi</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of HIV, ID and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>J Daniel</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Division of HIV, ID and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Jeffrey N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henrich</LastName><ForeName>Timothy J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deeks</LastName><ForeName>Steven G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Division of HIV, ID and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sauceda</LastName><ForeName>John A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Center for AIDS Prevention Studies, University of California, San Francisco, 550 16th Street, 3rd Floor, San Francisco, CA, 94158, USA. john.sauceda@ucsf.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 MH062246</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI158013</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 MH019105</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 AI157875</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 AI147159</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 AI126521</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 AI146268</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Behav Med</MedlineTA><NlmUniqueID>9421097</NlmUniqueID><ISSNLinking>1070-5503</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2021 Mar 24:2021.03.10.21253330. doi: 10.1101/2021.03.10.21253330</RefSource><PMID Version="1">33758881</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Coronavirus</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Mental health</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae of SARS-CoV-2 (PASC)</Keyword><Keyword MajorTopicYN="N">Recovering from COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-Cov-2</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>17</Day><Hour>7</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34918211</ArticleId><ArticleId IdType="pmc">PMC8675303</ArticleId><ArticleId IdType="doi">10.1007/s12529-021-10045-7</ArticleId><ArticleId IdType="pii">10.1007/s12529-021-10045-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nature Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Allday E. Another scary thing about COVID: Survivors aren&#x2019;t fully recovering. San Francisco Chronicle. September, 28, 2020. https://www.sfchronicle.com/health/article/Another-scary-thing-about-COVID-Survivors-15601758.php.</Citation></Reference><Reference><Citation>Brody JE. When symptoms of COVID-19 don&#x2019;t go away. New York Times. October 12, 2020. https://www.nytimes.com/2020/10/12/well/live/coronavirus-symptoms-covid-19-persistent.html.</Citation></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, et al. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi RT, Lynch JB, del Rio C. Mild or moderate COVID-19. N Eng J Med. 2020;383:1757&#x2013;1766. doi: 10.1056/NEJMcp2009249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcp2009249</ArticleId><ArticleId IdType="pubmed">32329974</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart G. My experience with COVID-19 &#x2013; not just another experience. The BMJ Opinion. Accessed on Feb. 1, 2021. https://blogs.bmj.com/bmj/2020/07/20/grant-stewart-my-experience-of-covid-19-not-just-another-experience/.</Citation></Reference><Reference><Citation>Yong, E. Long-haulers are redefining COVID-19. The Atlantic. August 19, 2020. https://www.theatlantic.com/health/archive/2020/08/long-haulers-covid-19-recognition-support-groups-symptoms/615382/.</Citation></Reference><Reference><Citation>Pope C, Mays N. Qualitative research: qualitative research: reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. BMJ. 1995;311:42. doi: 10.1136/bmj.311.6996.42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.311.6996.42</ArticleId><ArticleId IdType="pmc">PMC2550091</ArticleId><ArticleId IdType="pubmed">7613329</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes EA, O&#x2019;Connor RC, Perry H, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020;7:547&#x2013;560. doi: 10.1016/S2215-0366(20)30168-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30168-1</ArticleId><ArticleId IdType="pmc">PMC7159850</ArticleId><ArticleId IdType="pubmed">32304649</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020; 370, m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert SD, Loiselle CG. Health information&#x2014;seeking behavior. Qual Health Res. 2007;17:1006&#x2013;1019. doi: 10.1177/1049732307305199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1049732307305199</ArticleId><ArticleId IdType="pubmed">17928475</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson MO. The shifting landscape of health care: toward a model of health care empowerment. Am J Pub Health. 2011;20:265&#x2013;270. doi: 10.2105/AJPH.2009.189829.</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2009.189829</ArticleId><ArticleId IdType="pmc">PMC3020216</ArticleId><ArticleId IdType="pubmed">21164096</ArticleId></ArticleIdList></Reference><Reference><Citation>Halvorsen K, Dihle A, Hansen C, Nordhaug M, Jerpseth H, Tveiten S, Joranger P, Knutsen IR. Empowerment in healthcare: a thematic synthesis and critical discussion of concept analyses of empowerment. Patient Educ Couns. 2020;103:1263&#x2013;1271. doi: 10.1016/j.pec.2020.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pec.2020.02.017</ArticleId><ArticleId IdType="pubmed">32164960</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu PL. COVID-19 information seeking on digital media and preventive behaviors: the mediation role of worry. Cyberpsychol Behav Soc Netw. 2020;23:677&#x2013;682. doi: 10.1089/cyber.2020.0250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/cyber.2020.0250</ArticleId><ArticleId IdType="pubmed">32498549</ArticleId></ArticleIdList></Reference><Reference><Citation>Teti M, Schatz E, Liebenberg L. Methods in the time of COVID-19: the vital role of qualitative inquiries. Int J Qual Methods. 2020;19:1&#x2013;5. doi: 10.1177/1609406920920962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1609406920920962</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisinger RW, Lerner AM, Fauci AS. Human immunodeficiency virus/AIDS in the era of coronavirus disease 2019: a juxtaposition of 2 pandemics. J Infect Dis. 2021;XX:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083774</ArticleId><ArticleId IdType="pubmed">33825905</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Kelly JD, Lu S, et al. Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infections/COVID-19. medRxiv. March 13, 2021.&#xa0;10.1101/2021.03.11.21252311.</Citation></Reference><Reference><Citation>Guest G, MacQueen KM, Namey EE. Applied thematic analysis. Thousand Oaks, CA: SAGE Publications, Inc.; 2014.</Citation></Reference><Reference><Citation>Nowell LS, Norris JM, White DE, Moules NJ. Thematic analysis: striving to meet the trustworthiness criteria. Int J Qual Methods. 2017 doi: 10.1177/1609406917733847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1609406917733847</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77&#x2013;101. doi: 10.1191/1478088706qp063oa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/1478088706qp063oa</ArticleId></ArticleIdList></Reference><Reference><Citation>King N. Using templates in the thematic analysis of text. In: Cassell C, Symon G, editors. Essential guide to qualitative methods in organizational research. London, UK: Sage; 2004. pp. 257&#x2013;270.</Citation></Reference><Reference><Citation>Dedoose Version 7.0.23, web application for managing, analyzing, and presenting qualitative and mixed method research data (2016). Los Angeles, CA: SocioCultural Research Consultants, LLC.&#xa0;www.dedoose.com.</Citation></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, Chu HY. Sequelae in adults at 6 months after COVID-19 infection. JAMA Network Open. 2020;4: e210830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez JM, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infec. 2021; 82: 378&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellmuth J, Barnett TA, Asken BM, et al. Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. J Neurovirol. 2021;27:191&#x2013;195. doi: 10.1007/s13365-021-00954-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-021-00954-4</ArticleId><ArticleId IdType="pmc">PMC7852463</ArticleId><ArticleId IdType="pubmed">33528824</ArticleId></ArticleIdList></Reference><Reference><Citation>Horesh D, Brown AD. Traumatic stress in the age of COVID-19: a call to close critical gaps and adapt to new realities. Psychol Trauma. 2020;12:331&#x2013;335. doi: 10.1037/tra0000592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/tra0000592</ArticleId><ArticleId IdType="pubmed">32271070</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaseda ET, Levine AJ. Post-traumatic stress disorder: a differential diagnostic consideration for COVID-19 survivors. Clin Neuropsychol. 2020;34:1498&#x2013;1514. doi: 10.1080/13854046.2020.1811894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13854046.2020.1811894</ArticleId><ArticleId IdType="pubmed">32847484</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, De Lorenzo R, Conte C, et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain, Behav Immun. 2020;89:594&#x2013;600. doi: 10.1016/j.bbi.2020.07.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.07.037</ArticleId><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson TE, Kay ES, Turant B, et al. Healthcare empowerment and HIV viral control: mediating roles of adherence and retention in HIV care. Am J Prevent Med. 2018;54:756&#x2013;764. doi: 10.1016/j.amepre.2018.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2018.02.012</ArticleId><ArticleId IdType="pmc">PMC5962433</ArticleId><ArticleId IdType="pubmed">29656911</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimbell B, Boyd K, Kendall M, Iredale J, Murray SA. Managing uncertainty in advanced liver disease: a qualitative, multiperspective, serial interview study. BMJ Open. 2015;5:3009241. doi: 10.1136/bmjopen-2015-009241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2015-009241</ArticleId><ArticleId IdType="pmc">PMC4654301</ArticleId><ArticleId IdType="pubmed">26586325</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang X, He G. Effects of an uncertainty management intervention on uncertainty, anxiety, depression and quality of life of chronic obstructive pulmonary disease outpatients. Res Nurs Health. 2012;35:409&#x2013;418. doi: 10.1002/nur.21483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nur.21483</ArticleId><ArticleId IdType="pubmed">22511399</ArticleId></ArticleIdList></Reference><Reference><Citation>Nydegger LA, Hill MJ. Examining COVID-19 and HIV: the impact of intersectional stigma on short- and long-term health outcomes among African Americans. Int Soc Work. 2020;63(5):655&#x2013;659. doi: 10.1177/0020872820940017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0020872820940017</ArticleId><ArticleId IdType="pmc">PMC10846888</ArticleId><ArticleId IdType="pubmed">38323072</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>